Table 4 Differences in lipids, ILs and MMP-12 between T2DM patients with and without CV organ damage and differences in ILs and CV measures in T2DM patients with and without CV disease
From: Cardiovascular organ damage in type 2 diabetes mellitus: the role of lipids and inflammation
cIMT (μm) | > 90th percentile (64) | Within limits (127) | P |
|---|---|---|---|
HDL (mmol/L) | 1.19 ± 0.25 | 1.31 ± 0.30 | < 0.005 |
IL-18 (AU) | 1499 [790] | 1269 [582] | 0.01 |
cfPWV (m/s) | > 90th percentile (52) | Within limits (139) | P |
|---|---|---|---|
HDL | 1.13 ± 0.29 | 1.32 ± 0.27 | < 0.0001 |
MMP-12 (AU) | 158 [100] | 128 [89] | < 0.05 |
LVH | Yes (99) | No (92) | P |
|---|---|---|---|
IL-6 | 38 [28] | 34 [23] | < 0.05 |
MMP-12 (AU) | 155 [112] | 124 [86] | 0.01 |
CV disease | Yes (97) | No (94) | P |
|---|---|---|---|
IL-6 (AU) | 39 [28] | 32 [22] | 0.01 |
cfPWV (m/s) | 12.1 ± 2.6 | 10.7 ± 2.1 | < 0.05 |